Dr. Arun Selvaraju is a distinguished Medical Oncologist with over 18 years of clinical and translational expertise, specializing in Lung Cancer, Breast Cancer, and Cancers of Unknown Primary (CUP). As Clinical Lead at Hampshire Hospitals NHS Foundation Trust, he spearheads the Acute Oncology and CUP Services, with a legacy of scaling one of England’s largest Acute Oncology Units at University Hospital Southampton.Deeply committed to precision oncology, Dr. Selvaraju integrates next-generation sequencing (NGS) platforms such as FoundationOne CDx, Guardant360, and Tempus into routine care pathways. His research leadership spans national trials like Add-Aspirin, FOCUS-4, and TRACC, and he serves as Principal Investigator for PREMAC2—a study focused on patient-reported outcomes in acute oncology.Educated at Stanley Medical College and the Institute of Cancer Research, London, with credentials from the Royal College of Pathologists (MRCPathME), he brings a rare convergence of clinical insight, systems thinking, and diagnostics innovation. At Genoll, Dr. Selvaraju helps shape our translational framework for earlier detection and better outcomes in complex cancer phenotypes.